ADAM17 and COVID-19: High levels of ACE2 in the plasma, which may be a consequence of enhanced ADAM17 activity, correlate with severity of COVID-19; higher levels of ACE2 can be found in the plasma of smokers, individuals affected by diabetes, chronic obstructive pulmonary disease and other conditions that are considered COVID-19 comorbidities [170].